Healt


 ASX-listed Dental Stocks: Is there any relief coming in? PSQ, ONT, SIL

ASX-listed Dental Stocks: Is there any relief coming in? PSQ, ONT, SIL

July 01, 2020 02:50 PM AEST| By Team Kalkine Media

Due to the rising number of coronavirus infections, many businesses were shut down amid COVID-19-induced restrictions. At the same time, some businesses urged their employees to work from home to maintain business continuity and help slow the sprea.....

 Australian Healthcare Players in Race to Develop COVID-19 Treatment – NOX, MSB, DXB

Australian Healthcare Players in Race to Develop COVID-19 Treatment – NOX, MSB, DXB

June 30, 2020 01:28 PM AEST| By Team Kalkine Media

The outbreak of coronavirus pandemic has driven the healthcare sector into spotlight, initiating a race to develop preventive and therapeutic interventions. The severity of COVID-19 can be comprehended by over 10 million cases and more than 500k de.....

 Future of Healthcare and IVF Businesses: Lens on FPH, SHL, MVF, VRT

Future of Healthcare and IVF Businesses: Lens on FPH, SHL, MVF, VRT

June 30, 2020 12:20 AM AEST| By Hina Chowdhary

Australia has a robust healthcare system that is deemed as one of the best across the world. According to the Australian Healthcare and Hospitals Association (AHHA), in the Australian healthcare sector, the total expenditure is nearly A$140 billion.....

 Health care players RMD and CSL stock prices close to their 52-week high levels

Health care players RMD and CSL stock prices close to their 52-week high levels

June 29, 2020 06:45 PM AEST| By Team Kalkine Media

Worldwide, Australian health system is known as one of the best, in terms of offering reasonable and secure health care for people. As per Australian Industry and Skills Committee, the health care industry is one of the leading employing industries.....

 4 Healthcare Stocks to Watch Amid Another Round of Stock Market Downtrend

4 Healthcare Stocks to Watch Amid Another Round of Stock Market Downtrend

June 29, 2020 01:14 PM AEST| By Team Kalkine Media

Prompted by a second wave of coronavirus infection in several countries, share markets around the world plunged, eliminating all the gains of the last few sessions. Several nations across the globe are struggling to contain the swift spread of the.....

 Government urged to continue MBS-funded telehealth services: ResMed, Resapp to reap the benefits

Government urged to continue MBS-funded telehealth services: ResMed, Resapp to reap the benefits

June 27, 2020 02:47 PM AEST| By Team Kalkine Media

The Australian government had extended temporary Medicare Benefit Schedule (MBS) telehealth items on 13 March 2020 to assist in reducing the risk of community transmission of COVID-19 and protect patients and health care providers. The new temporar.....

 Two Healthcare Stocks Worth Monitoring: Dimerix, Cynata Therapeutics 

Two Healthcare Stocks Worth Monitoring: Dimerix, Cynata Therapeutics 

June 27, 2020 01:55 PM AEST| By Team Kalkine Media

Healthcare has always been one of the attractive sectors for investments, as its growth is not much dependent on economic cycles. However, this time, the crisis is different, and different segments of the sector have witnessed different impacts, ow.....

 Mapping the Genomic Charter: Victoria on COVID-19 infections & Healthcare Stocks under Watch Zone

Mapping the Genomic Charter: Victoria on COVID-19 infections & Healthcare Stocks under Watch Zone

June 26, 2020 07:58 PM AEST| By Team Kalkine Media

Globally, there have been more than 9.29 million confirmed cases of COVID-19, including 479,133 deaths, reported to WHO as of 2:25 PM CEST, 25 June 2020. In Australia, between 25 January 2020 to 25 June 2020 (2:25pm CEST), there have been nearly 7.....

 Nyrada’s Lead Programs Advancing Well, Minimal Impact from COVID-19

Nyrada’s Lead Programs Advancing Well, Minimal Impact from COVID-19

June 26, 2020 02:42 PM AEST| By Team Kalkine Media

Australian listed pre-clinical stage drug discoverer and developer Nyrada Inc. (ASX: NYR) is initially focussing on the developing new treatments for cardiovascular and neurodegenerative diseases, specialising in novel small molecule drugs. Additio.....

 Why did Mayne Pharma and Sonic Healthcare stock end ~5% higher today?

Why did Mayne Pharma and Sonic Healthcare stock end ~5% higher today?

June 24, 2020 08:01 PM AEST| By Kunal Sawhney

  Summary Several ASX-listed healthcare companies are backed by numerous advanced technologies and looking at the current opportunities, countless momentous developments are anticipated in the sector. Mayne Pharma’s oral contraceptive...

 Healthcare Sector Defying the Norms: COVID-19 Vaccines Under Development and Related Stocks

Healthcare Sector Defying the Norms: COVID-19 Vaccines Under Development and Related Stocks

June 23, 2020 08:15 PM AEST| By Team Kalkine Media

COVID-19 threat still looms with countries struggling to eliminate the novel coronavirus, SARS-CoV-2. While most geographies are grappling with the first wave of virus, the ones who did become COVID-19-free are now facing the second wave. Globally,.....

 ASX-listed Digital Healthcare Stock Amid COVID-19: A Look At RAP, HRD, TD1

ASX-listed Digital Healthcare Stock Amid COVID-19: A Look At RAP, HRD, TD1

June 23, 2020 03:35 PM AEST| By Team Kalkine Media

The healthcare sector across the world is struggling with the myriad challenges thrown by the COVID-19 pandemic, and virtual healthcare is fast becoming the global response of private as well as the public healthcare system to the SARS-CoV-2 outbre.....

 Noxopharm to Initiate COVID-19 Trial Program in Europe, Continues Discussions with FDA

Noxopharm to Initiate COVID-19 Trial Program in Europe, Continues Discussions with FDA

June 22, 2020 04:03 PM AEST| By Team Kalkine Media

Australian clinical stage drug developer, Noxopharm Limited (ASX:NOX) notified in its latest update the commencement of NOXCOVID clinical trial program in Europe, focusing on safety and proof-of principle endpoints of Veyonda® as a potential tr.....

 BPH Investee Cortical Commences US FDA Filling for BARM, Signs Licence and Co-operation Agreement with Philips

BPH Investee Cortical Commences US FDA Filling for BARM, Signs Licence and Co-operation Agreement with Philips

June 22, 2020 01:01 PM AEST| By Team Kalkine Media

Cortical has now begun the FDA 510K filing process for BARM in the USA assisted by its strategic investor Intuitive X, with FDA approval being a necessary precursor for sales of BARM to commence in the USA. Notably, Cortical already has achieved TG.....

 What’s latest with these ASX-listed cannabis stocks- MXC, THC, BDA

What’s latest with these ASX-listed cannabis stocks- MXC, THC, BDA

June 21, 2020 12:00 AM AEST| By Team Kalkine Media

Cannabis industry comprises companies that provide, support or are involved in the R&D, distribution, as well as sale of medicinal along with recreational cannabis. Cannabis has started to gain broader acceptance globally and its use has been l.....

 ASX biotech companies creating a pandemic-free buzz!

ASX biotech companies creating a pandemic-free buzz!

June 21, 2020 12:00 AM AEST| By Team Kalkine Media

As on 19 June 2020, the “pneumonia-like” illness has taken 456,432 lives with 8,538,928 confirmed cases recorded worldwide.  And with no sign to the ending of this human loss, an indispensable need for a vaccine or a treatment has .....

 Healthcare minnow eSense signs two JV Agreements in four days; stock ends ~27% higher

Healthcare minnow eSense signs two JV Agreements in four days; stock ends ~27% higher

June 19, 2020 05:50 PM AEST| By Team Kalkine Media

The ongoing COVID-19 turmoil has proved to be an opportunity for healthcare companies. While some burgeoning healthcare players are engaged in the development of vaccine or treatment, some diagnostic companies are coming up with rapid virus detecti.....

 Get Acquainted with Prescient Therapeutics’ Next Generation Immunotherapy Platform

Get Acquainted with Prescient Therapeutics’ Next Generation Immunotherapy Platform

June 19, 2020 11:39 AM AEST| By Team Kalkine Media

Prescient Therapeutics Limited (ASX:PTX) is a clinical-stage oncology company developing personalised medicine approaches to cancer, including cellular as well as targeted therapies. The targeted therapies include two drug candidates, PTX-200 and P.....

 Why did PharmAust’s stock close ~23% higher today?

Why did PharmAust’s stock close ~23% higher today?

June 18, 2020 10:27 PM AEST| By Kunal Sawhney

Healthcare sector has been one of the best-performing industries on the Australian Securities Exchange (ASX) from the previous year. Several companies from the healthcare sector in Australia have witnessed a surge in share price despite the market .....

 Another Golden Feather in Prescient’s Hat, PTX-200 Receives Two US Patents

Another Golden Feather in Prescient’s Hat, PTX-200 Receives Two US Patents

June 17, 2020 05:11 PM AEST| By Team Kalkine Media

Well-known for developing breakthrough targeted and personalised medicines approaches to treat cancer, Prescient Therapeutics Limited (ASX:PTX) has been gaining attention on the back of its recent achievements. Building on this momentum, on 17 June.....

AU_advertise

Advertise your brand on Kalkine Media

Recent Articles






Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.